Adenoid hypertrophy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for moderate to severe adenoid hypertrophy in children and are unwilling to undergo surgical treatment; (2) Age 3 ~ 12 years old gender is not limited; (3) The informed consent process is in accordance with the regulations and the legal guardian or the participating children (> 8 years old) jointly sign the informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) Patients who have undergone adenoidectomy; (2) Patients with severe nasal septum deviation nasal polyps nasal masses laryngeal and tracheal diseases etc. that cause breathing difficulties; (3) Patients who have suffered from acute upper and lower respiratory tract infections in the past 2 weeks; (4) Patients with metabolic or immunodeficiency diseases as well as severe dysfunction of important organs such as the heart liver kidney and brain; (5) Patients who have used corticosteroids antibiotics or immunomodulatory drugs in the past 4 weeks; (6) Patients who are allergic to the experimental drugs; (7) Patients who in the judgment of the researchers have other diseases or conditions that reduce the possibility of enrollment or complicate enrollment such as unstable living environment inconvenient transportation etc. which are likely to cause loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Points for primary symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Points for secondary symptoms;Adenoid size;OSA-18 Quality of life score;Operation rate; | — |
Countries
China
Contacts
The First Affiliated Hospital of Yunnan University of Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine)